Seelos Therapeutics, Inc. (SEEL)

Seelos Therapeutics Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Year Ending	TTM	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Cash & Equivalents	0.52	3	15.53	78.73	15.66	10.26
Cash & Cash Equivalents	0.52	3	15.53	78.73	15.66	10.26
Cash Growth	-96.27%	-80.71%	-80.27%	402.71%	52.64%	24330.95%
Receivables	0.97	0.76	0	0	0	0
Other Current Assets	2.06	1.64	7.14	4.73	1.83	0.84
Total Current Assets	3.55	5.4	22.67	83.46	17.49	11.1
Property, Plant & Equipment	0.06	0.02	0.07	0.04	0	0
Total Long-Term Assets	0.06	0.02	0.07	0.04	0	0
Total Assets	3.61	5.42	22.75	83.5	17.49	11.1
Accounts Payable	15.27	16.4	3.63	1.69	1.89	0.8
Current Debt	13.14	14.23	11.92	1.07	2.43	0
Other Current Liabilities	8.31	8.3	9.61	5.53	3.11	9.98
Total Current Liabilities	36.72	38.93	25.16	8.29	7.43	10.78
Long-Term Debt	0	0	8.2	17.89	7.29	0
Other Long-Term Liabilities	0	0	0	0	0.2	0.33
Total Long-Term Liabilities	0	0	8.2	17.89	7.49	0.33
Total Liabilities	36.72	38.93	33.36	26.18	14.92	11.1
Total Debt	13.14	14.23	20.12	18.96	9.72	0
Debt Growth	-21.71%	-29.29%	6.14%	94.96%	-	-
Retained Earnings	-255.29	-252.63	-214.74	-141.21	-75.16	-56.06
Shareholders' Equity	-33.1	-33.51	-10.61	57.32	2.57	-0.01
Net Cash / Debt	-12.61	-11.23	-4.59	59.78	5.94	10.26
Net Cash / Debt Growth	-	-	-	906.67%	-42.13%	-
Net Cash Per Share	-7.76	-18.34	-10.35	157.84	31.83	121.26
Working Capital	-33.17	-33.53	-2.48	75.17	10.07	0.32
Book Value Per Share	-20.36	-54.71	-23.94	151.36	13.79	-0.08

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).